Publicaciones en colaboración con investigadores/as de Norwegian University of Science and Technology (7)

2023

  1. Design and methodological considerations for biomarker discovery and validation in the Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) Program

    Annals of Epidemiology, Vol. 77, pp. 1-12

2021

  1. Mass spectrometry for the evaluation of monoclonal proteins in multiple myeloma and related disorders: an International Myeloma Working Group Mass Spectrometry Committee Report

    Blood Cancer Journal, Vol. 11, Núm. 2

2020

  1. Inhibition of HSP90 and Activation of HSF1 Diminish Macrophage NLRP3 Inflammasome Activity in Alcohol-Associated Liver Injury

    Alcoholism: Clinical and Experimental Research, Vol. 44, Núm. 6, pp. 1300-1311

2019

  1. Author Correction: ‘Stealth’ corporate innovation: an emerging threat for therapeutic drug development (Nature Immunology, (2019), 20, 11, (1409-1413), 10.1038/s41590-019-0503-1)

    Nature Immunology

  2. ‘Stealth’ corporate innovation: an emerging threat for therapeutic drug development

    Nature Immunology

2014

  1. Comparing algorithms for automated vessel segmentation in computed tomography scans of the lung: The VESSEL12 study

    Medical Image Analysis, Vol. 18, Núm. 7, pp. 1217-1232

2008

  1. Origin of calretinin-containing, vesicular glutamate transporter 2-coexpressing fiber terminals in the entorhinal cortex of the rat

    Journal of Comparative Neurology, Vol. 506, Núm. 2, pp. 359-370